Connect with us


Tauriga Sciences Inc. (OTCMKTS:TAUG) Completes Payment For the Tauri-Gum Production Run



Tauriga Sciences Inc. (OTCMKTS:TAUG) has announced the completion of payment for the entirety of the recently announced, largest Tauri-Gum™ production run in its history.

Tauriga completes payment for Tauri-Gum™ production run

The life sciences company paid $267,500 for the production Run, leading to 70,000 to 72,000 Tauri-Gum blister packs that comprise all the eight Tauri-Gum™ versions. The blister packs completed include 25mg CBD-infused pomegranate flavor, 25mg CBD infused blood orange flavors, 60mg Vitamin C+ 100mg zinc pear bellini flavor, 25mg CBG infused peach-lemon flavor, 25 mg CBD infused mint flavor, 50 mg caffeine infuse4d cherry lime rickey flavors, 25mg CBG infused black currant flavor and 2,000 IUs vitamin D3 infused golden raspberry flavor.

The eight Tauri-Gum™ product lines comprising eight different versions, five are CBD infused, and three are CBD free. Most importantly, the product line is Halal Certifies, Kosher Certified, Vegan Formulated, Gluten-Free, Non0GMO, Allergen Free, Lab Tested, All-natural Flavours, No THC, and $10 million Product Liability Insurance Coverage.

The company increased CBD and CBG infusion concentrations to 25mg per chewing gum. Thus took immediate effect and has been incorporated in the production run for the Tauri-Gum(TM SKUs.

Tauriga completes production run for Tauri-Pet™ pet treat

Recently, the company announced the completion of an initial production run for its novel CBD infused, peanut butter flavor pet treat called Tauri-Pet™. The product comprises square-shaped, peanut butter flavor, cannabinoid-infused dog treats, it 5mg CBD per treat. There are 30 treats per Tauri-Pet™ pouch which is around 150mg CBD in total. The Tauri-Pet™ incorporates a full spectrum CBD, and it is premium quality and all-natural flavor made in the US.

The US pet market is currently estimated to be around $7 to $10 billion per year, driven by CBD products and other ingredients. Tauriga is planning to develop other versions of the Tauri-Pet™ product going forward. The pet treat’s commercial launch will take place through the company’s e-commerce platform and other possible distribution partners. Similarly, the company will create a link to Tauri-Pet™ on its e-commerce site.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.


Business3 days ago

THC Biomed Intl Ltd (OTCMKTS: THCBF) Amends its Health Canada Licence to Include Three Strata Units at its Acland Road Location

Post Views: 5 It took only a year for THC Biomed Intl Ltd (OTCMKTS: THCBF) to obtain a rare license...

Business3 days ago

Tetra Bio-Pharma Inc. (OTCMKTS: TBPMF) Obtains an Approval of the Proposed Protocol Modifications to Accelerate the REBORN Study

Post Views: 37 Clinical trials are an essential component of any drug discovery and development program. Innovative research initiatives are...

Business3 days ago

The Appointment of Philip Goldberg, Formerly of Green Leaf Medical, to the Board of Directors of Columbia Care Inc. (OTCMKTS: CCHWF)

Post Views: 6 The growing acceptance and recognition of marijuana for its medical purposes has made an impact on cannabis...

Business3 days ago

Surna Inc, (OTCMKTS: SRNA) Expands its Line of Curated HVACD Family Products with the Introduction of EnviroPro™ Air Handler

Post Views: 6 The cultivation of cannabis comes with a myriad of challenges. Designing cultivation facilities and deploying the systems...

Business4 days ago

Mydecine Innovations Group Inc. (OTCMKTS: MYCOF) Supports the Launch of Version 2.0, a Digital Health Platform by its Subsidiary Mindleap Health

Post Views: 3 The COVID 19 pandemic took the world by storm and has left hundreds of thousands of people...


HempMeds Latin American Operations, a subsidiary of Medical Marijuana, Inc. (OTCMKTS: MJNA), Announces a 12% Revenue Increase in June 2021 Compared to June 2020

Post Views: 18 What comes to mind when you hear the words, “Medical marijuana?” It is seemingly regarded as the...